Relationship between preoperative heart rate variability, postoperative pain and quality of recovery in breast cancer patients undergoing partial mastectomy.
Not Applicable
Recruiting
- Conditions
- Not Applicable
- Registration Number
- KCT0004858
- Lead Sponsor
- Inha University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
ASA classification I ~III, Patients of partial mastectomy for breast cancer surgery
Exclusion Criteria
Patients with heart and neurological diseases
Patients with pacemakers or defibrillators
Pregnant patient
Drugs that may affect preoperative heart rate variability. (antiarrhythmic agent, antidepressants, antipsychotics, atnihistamine, antiemetics, beta blocker)
Subjects who are vulnerable by the definition of the Institutional review committee where the clinical trial is conducted
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of recovery
- Secondary Outcome Measures
Name Time Method Postoperative pain score
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link heart rate variability to postoperative pain in breast cancer patients?
How does preoperative heart rate variability compare to standard pain assessment tools in predicting recovery outcomes after partial mastectomy?
Are there specific biomarkers in heart rate variability that can predict quality of recovery in breast cancer patients undergoing partial mastectomy?
What adverse events are associated with heart rate variability monitoring in breast cancer patients and how are they managed?
How do heart rate variability metrics compare to other autonomic nervous system indicators in predicting postoperative outcomes for breast cancer patients?